Lexicon Pharmaceuticals, Inc. (LXRX): Price and Financial Metrics
LXRX Price/Volume Stats
| Current price | $0.72 | 52-week high | $2.45 |
| Prev. close | $0.66 | 52-week low | $0.28 |
| Day low | $0.66 | Volume | 7,858,600 |
| Day high | $0.77 | Avg. volume | 10,972,191 |
| 50-day MA | $0.59 | Dividend yield | N/A |
| 200-day MA | $0.97 | Market Cap | 259.19M |
LXRX Stock Price Chart Interactive Chart >
Lexicon Pharmaceuticals, Inc. (LXRX) Company Bio
Lexicon Pharmaceuticals is a biopharmaceutical company focused on developing breakthrough treatments for human disease. Lexicon has clinical-stage drug programs for diabetes and carcinoid syndrome in progress. The company was founded in 1995 and is based in The Woodlands, Texas.
LXRX Latest News Stream
| Event/Time | News Detail | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
LXRX Price Returns
| 1-mo | 5.11% |
| 3-mo | 83.77% |
| 6-mo | 2.11% |
| 1-year | -58.86% |
| 3-year | -58.62% |
| 5-year | -63.08% |
| YTD | -2.51% |
| 2024 | -51.73% |
| 2023 | -19.90% |
| 2022 | -51.52% |
| 2021 | 15.20% |
| 2020 | -17.59% |